Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from Northern Germany

  • C. Klein
  • , P. Vieregge
  • , J. Hagenah
  • , M. Sieberer
  • , E. Doyle
  • , H. Jacobs
  • Stanford University
  • Albert Einstein College of Medicine of Yeshiva University
  • Departments of Neurology and Neuroscience Program
  • Harvard University

Abstract

A founder haplotype on chromosome 2p for autosomal dominant Parkinson's disease (PD) has been postulated for two families of Northern European descent, and a new mutation in the α-synuclein gene (Ala30Pro) has been found in a German PD family. We evaluated 85 German PD patients and 85 ethnically matched controls for shared markers on chromosome 2p and for the new α-synuclein mutation. We found no evidence for linkage disequilibrium, suggesting that the putative founder mutation on chromosome 2p is not a common cause of PD in the local population. Furthermore, no patient carried the Ala30Pro change, supporting earlier findings that mutations in the α-synuclein gene are extremely rare.

OriginalspracheEnglisch
ZeitschriftAnnals of Human Genetics
Jahrgang63
Ausgabenummer4
Seiten (von - bis)285-291
Seitenumfang7
ISSN0003-4800
DOIs
PublikationsstatusVeröffentlicht - 01.07.1999

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Fingerprint

Untersuchen Sie die Forschungsthemen von „Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from Northern Germany“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren